Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,839 companies covered, latest filing Oct 23.

  • $306M bought by 81 insiders at 62 companies
  • $364M sold by 57 insiders outside a trading plan
  • $2.6B sold by 257 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past week, each insider's filings added up.

  1. SAFXXCF Global
    EEME Energy SPV I, LLC10% owner
    119M shares at $1.19 Oct 16 +109% to stake
    $142M
  2. CRBGCorebridge Financial
    Life Insurance Co Nippon10% owner
    2,032,734 shares at $34.27 Oct 14–21, 6 filings +1.6% to stake 2 superinvestors bought in Q2
    $69.7M
  3. PAMPampa Energia
    Marcos Marcelo MindlinDirector
    435,000 shares at $80.78 Oct 15 +6.4% to stake
    $35.1M
  4. PEPPepsiCo
    Robert C PohladDirector
    184,646 shares at $128.28 Oct 14 +74% to stake 3 superinvestors bought in Q2
    $23.7M
  5. DOLEDole PLC
    Pale Fire Capital SE10% owner, +4 joint filers
    648,356 shares at $13.19 Oct 20–22 +6.7% to stake
    $8.6M
  6. APLDApplied Digital
    Jason Gechen ZhangPresident
    300,000 shares at $18.86 Oct 16 +12% to stake 5 superinvestors bought in Q2
    $5.7M
  7. BORRBorr Drilling
    Tor Olav TroimDirector
    500,000 shares at $4.60 Oct 15 +1.3% to stake
    $2.3M
  8. RENTRent the Runway
    Nexus Capital Management LPDirector, +9 joint filers
    632,922 shares at $3.55 Oct 21 +15% to stake
    $2.2M
  9. RENTRent the Runway
    CHS US Investments LLC10% owner, +4 joint filers
    458,245 shares at $3.55 Oct 21 +2% to stake
    $1.6M
  10. FBKFB Financial
    Orrin H Ingram IIDirector
    29,081 shares at $52.88 Oct 20 +31% to stake
    $1.5M

Biggest sales

Past week, each insider's filings added up. Planned sales are marked.

  1. IHTInnSuites Hospitality Trust
    James F WirthCEO
    43,111 shares at $46,654.38 Oct 20 0.5% of stake Planned sale (10b5-1)
    $2B
  2. INSWInternational Seaways
    Famatown Finance Ltd10% owner, +2 joint filers
    1,106,190 shares at $97.01 Apr 30–Oct 8 14% of stake
    $107M
  3. SNOWSnowflake
    Frank SlootmanDirector
    300,000 shares at $316.43 Oct 19 94% of stake Planned sale (10b5-1)
    $94.9M
  4. TALOTalos Energy
    Empresarial De Capitales S.a. De C.v. Control10% owner
    4,893,590 shares at $17.55 Oct 15–19, 2 filings 17% of stake
    $85.9M
  5. TRVTravelers
    Alan D SchnitzerCEO
    88,900 shares at $396.77 Oct 21 23% of stake
    $35.3M
  6. PATHUiPath
    Daniel DinesCEO
    2,500,000 shares at $13.23 Oct 15–16 7.9% of stake Planned sale (10b5-1)
    $33.1M
  7. UTHRUnited Therapeutics
    Martine A RothblattCEO
    57,000 shares at $553.66 Oct 15–22, 6 filings 15% of stake Planned sale (10b5-1)
    $31.6M
  8. MUMicron Technology
    Scott J DeboerPres. & Chief Tech & Prod Offr
    28,545 shares at $900.00 Oct 16 16% of stake Planned sale (10b5-1)
    $25.7M
  9. NTRANatera
    Matthew RabinowitzChair
    50,000 shares at $402.64 Oct 15 2.3% of stake Planned sale (10b5-1)
    $20.1M
  10. AFLAflac
    Japan Post Holdings Co., Ltd.10% owner
    168,611 shares at $118.29 Oct 14–15, 2 filings 0.3% of stake Planned sale (10b5-1)
    $19.9M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days, most buyers first

  1. TSMTaiwan Semiconductor 19 insiders, $80K

    Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more

    Latest buy Oct 7 19 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group 11 insiders, $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. FULH. B. Fuller 9 insiders, $1.1M

    R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more

    Latest buy Oct 16 1 executive 1 superinvestor bought in Q2
  4. RAPPRapport Therapeutics 6 insiders, $1.7M

    Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more

    Latest buy Oct 23 1 executive
  5. ATCHAtlasClear 5 insiders, $163K

    Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more

    Latest buy Sep 25 3 executives
  6. RGCORGC Resources 5 insiders, $85K

    John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more

    Latest buy Oct 1 3 executives
  7. WVVIWillamette Valley Vineyards 5 insiders, $75K

    Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more

    Latest buy Oct 12 3 executives
  8. MPBMid Penn Bancorp 5 insiders, $25K

    Matthew G De Soto Director, Albert J. Evans Director, Kimberly J Brumbaugh Director, Theodore W Mowery Director, +1 more

    Latest buy Sep 30
  9. DXDynex Capital 4 insiders, $245K

    Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO

    Latest buy Oct 20 4 executives
  10. ANIXAnixa Biosciences 4 insiders, $203K

    Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director

    Latest buy Oct 22 2 executives

VITL insider trades

Every open-market buy and sale in VITL, one row per filing, newest first

VITL page
All Buys Sales
Everyone CEOs CFOs Executives Directors 10% owners
Any size $100K+ $1M+ $10M+
Hide planned sales
  1. Reena Chauhan Van Hoven Chief People Officer
    VITLVital Farms
    Buy
    $20K 2,242 shares at $8.92 +9.5% to stake
    Traded May 19 Filed May 21
    ↗
  2. Glenda J Flanagan Director
    VITLVital Farms
    Buy
    $51K 6,100 shares at $8.33 +19% to stake
    Traded May 18 Filed May 21
    ↗
  3. Kelly J. Kennedy Director
    VITLVital Farms
    Buy
    $21K 2,500 shares at $8.40 +12% to stake
    Traded May 14 Filed May 21
    ↗
  4. William B. Cyr Director
    VITLVital Farms
    Buy
    $51K 6,000 shares at $8.52 +77% to stake
    Traded May 14 Filed May 21
    ↗
  5. Joseph Michael Holland Chief Supply Chain Officer
    VITLVital Farms
    Buy
    $100K 12,484 shares at $8.00 +49% to stake
    Traded May 14 Filed May 21
    ↗
  6. Stephanie Coon Chief Strategy Officer
    VITLVital Farms
    Buy
    $50K 5,895 shares at $8.42 +10% to stake
    Traded May 15 Filed May 19
    ↗
  7. Gisel Ruiz Director
    VITLVital Farms
    Buy
    $50K 6,151 shares at $8.13 +15% to stake
    Traded May 13 Filed May 19
    ↗
  8. Kofi Owusu Amoo-Gottfried Director
    VITLVital Farms
    Buy
    $20K 2,375 shares at $8.45 +8.3% to stake
    Traded May 15 Filed May 19
    ↗
  9. Kathryn McKeon CMO and GM, Butter
    VITLVital Farms
    Buy
    $5,001 604 shares at $8.28 +1.2% to stake
    Traded May 14 Filed May 18
    ↗
  10. Peter Nicholas Pappas CSO and President, Eggs
    VITLVital Farms
    Buy
    $30K 3,500 shares at $8.51 +4.3% to stake
    Traded May 14 Filed May 18
    ↗
  11. Denny Marie Post Director
    VITLVital Farms
    Buy
    $25K 3,000 shares at $8.23 +18% to stake
    Traded May 13 Filed May 15
    ↗
  12. Matthew Ohayer 10% owner
    VITLVital Farms
    Planned sale
    $305K 15,000 shares at $20.33 0.2% of stake
    Traded Mar 2 Filed Mar 13
    ↗
  13. Karl Khoury Director
    VITLVital Farms
    Buy
    $92K 5,000 shares at $18.45 +4.4% to stake
    Traded Mar 9 Filed Mar 11
    ↗
  14. William B. Cyr Director
    VITLVital Farms
    Buy
    $98K 4,750 shares at $20.70 +156% to stake
    Traded Mar 2 Filed Mar 4
    ↗
  15. Matthew Ohayer Chair
    VITLVital Farms
    Planned sale
    $558K 20,000 shares at $27.91 0.3% of stake
    Traded Feb 2 Filed Feb 4
    ↗
  16. Matthew Ohayer Chair
    VITLVital Farms
    Planned sale
    $771K 25,000 shares at $30.85 0.4% of stake
    Traded Jan 2 Filed Jan 6
    ↗
  17. Matthew Ohayer Chair
    VITLVital Farms
    Planned sale
    $176K 5,000 shares at $35.25 0.1% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
    ↗
  18. Russell Diez-Canseco CEO
    VITLVital Farms
    Planned sale
    $587K 16,734 shares at $35.05 2.5% of stake
    Traded Dec 15, 2025 Filed Dec 17, 2025
    ↗
  19. Matthew Ohayer Chair
    VITLVital Farms
    Planned sale
    $829K 25,000 shares at $33.17 0.4% of stake
    Traded Dec 1, 2025 Filed Dec 3, 2025
    ↗
  20. Matthew Ohayer Chair
    VITLVital Farms
    Planned sale
    $987K 30,000 shares at $32.90 0.5% of stake
    Traded Nov 3–4 Filed Nov 5, 2025
    ↗
  21. Russell Diez-Canseco CEO
    VITLVital Farms
    Planned sale
    $429K 9,667 shares at $44.39 1.4% of stake
    Traded Oct 8, 2025 Filed Oct 10, 2025
    ↗

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,839 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.